Inactive Instrument
Epigenomics AG Stock Deutsche Boerse AG
Stocks
DE000A0BVT96
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - EUR | - |
|
| 04-02 | Epigenomics AG Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 25-07-22 | Epigenomics AG Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
| Market Cap | 965K 1.1M 890K 822K 1.56M 105M 1.59M 10.67M 4.15M 51.73M 4.14M 4.04M 179M | P/E 2024 |
-0.29x | P/E 2025 | -2.51x |
|---|---|---|---|---|---|
| Enterprise Value | 11.93M 13.62M 11.01M 10.17M 19.3M 1.3B 19.65M 132M 51.38M 640M 51.16M 50.02M 2.21B | EV / Sales 2024 |
-
| EV / Sales 2025 | 490x |
| Free-Float |
70.75% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Frederic Hilke
IRC | Investor Relations Contact | - | - |
| Corporate Officer/Principal | 55 | 2024-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Helge Lubenow
CHM | Chairman | 58 | 2023-02-28 |
Alexander Link
BRD | Director/Board Member | 55 | 2020-05-31 |
Jochen Hummel
BRD | Director/Board Member | 56 | 2024-02-04 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.07% | -4.44% | +113.06% | +136.69% | 4.48B | ||
| -3.17% | -6.01% | +71.72% | +233.77% | 3.33B | ||
| -0.95% | -2.17% | -29.90% | -41.82% | 1.96B | ||
| -1.61% | +2.88% | +151.76% | -40.88% | 1.94B | ||
| -2.68% | -3.33% | +49.32% | +173.04% | 1.46B | ||
| -2.70% | -7.69% | +121.54% | -52.71% | 873M | ||
| -3.58% | -4.88% | -10.03% | +45.39% | 881M | ||
| -1.61% | +2.53% | -36.86% | -17.99% | 487M | ||
| -8.72% | -18.82% | -5.99% | - | 488M | ||
| Average | -2.79% | -2.68% | +47.18% | +54.44% | 1.77B | |
| Weighted average by Cap. | -1.91% | -2.57% | +71.08% | +95.26% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 24K 27.4K 22.15K 20.46K 38.82K 2.62M 39.53K 266K 103K 1.29M 103K 101K 4.45M |
| Net income | -3.35M -3.83M -3.09M -2.86M -5.42M -366M -5.52M -37.09M -14.43M -180M -14.37M -14.05M -622M | -314K -358K -290K -268K -508K -34.28M -517K -3.47M -1.35M -16.84M -1.35M -1.32M -58.28M |
| Net Debt | 10.46M 11.94M 9.65M 8.91M 16.91M 1.14B 17.22M 116M 45.02M 561M 44.83M 43.83M 1.94B | 10.97M 12.52M 10.12M 9.35M 17.74M 1.2B 18.06M 121M 47.22M 588M 47.02M 45.98M 2.04B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
















